JGACX
Price
$29.45
Change
-$0.33 (-1.11%)
Updated
Jun 13 closing price
Net Assets
21.18B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

JGACX vs RGEBX

Header iconJGACX vs RGEBX Comparison
Open Charts JGACX vs RGEBXBanner chart's image
JPMorgan Growth Advantage C
Price$29.45
Change-$0.33 (-1.11%)
VolumeN/A
Net Assets21.18B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
JGACX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGACX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGACX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. JGACX (21.2B). JGACX (0.00) and RGEBX (0.00) have matching dividends . JGACX was incepted earlier than RGEBX: JGACX (19 years) vs RGEBX (11 years). JGACX (1.59) is less costly to investors than RGEBX (1.09). JGACX is a more actively managed with annual turnover of: 28.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than JGACX: RGEBX (250) vs JGACX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. JGACX (3.59). RGEBX (45.42) and JGACX (44.86) have equivalent 5 years return.
JGACXRGEBXJGACX / RGEBX
Total Expense Ratio1.491.09137%
Annual Report Gross Expense Ratio1.591.09146%
Fund Existence19 years11 years-
Gain YTD1.2384.82926%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets21.2B306B7%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.597.6847%
Returns for 3 years66.4851.01130%
Returns for 5 years44.8645.4299%
Returns for 10 years105.3765.87160%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd